Heterogeneous nuclear ribonucleoprotein A3 pseudogene 12 (HNRNPA3P12)

Heterogeneous nuclear ribonucleoprotein A3 pseudogene 12 (HNRNPA3P12) is a **processed pseudogene** in the human genome, corresponding to the HNRNPA3 gene family[1][2][5][7][10]. Pseudogenes like HNRNPA3P12 originate from duplication or retrotransposition of functional genes but have lost the capacity to code for a functional protein, usually due to disabling mutations[2][8]. There is no evidence that HNRNPA3P12 is transcribed into protein, serves as a therapeutic target, or participates in biological or disease pathways[1][2][5]. Functional studies and disease associations published for HNRNPA3 proteins pertain to active, coding genes and not to pseudogenes such as HNRNPA3P12[4][3]. As such, HNRNPA3P12 is generally not considered for therapeutic targeting or drug interaction assessments. **Note:** - HNRNPA3P12 is sometimes confused with the functional HNRNPA3 gene, which is involved in RNA processing and has been studied in disease contexts[3][4]. However, HNRNPA3P12 itself is a non-coding, non-functional pseudogene. - No drugs, biomarkers, or clinical significance has been attributed specifically to HNRNPA3P12 in the literature or databases as of this search.

Other names

HNRNPA3P12heterogeneous nuclear ribonucleoprotein A3 pseudogene 12